3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Sarcoma
1
Genitourinary
1
CNS
1
Conditions
Glioblastoma
13
Brain Neoplasms
12
Neuroblastoma
11
Gliosarcoma
7
Astrocytoma
7
Oligodendroglioma
5
Glioma
5
Medulloblastoma
4
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
Wilms Tumor
2
Spinal Cord Neoplasms
2
Rhabdoid Tumor
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Optic Nerve Glioma
2
Lung Neoplasms
2
Familial ependymoma
2
Diffuse Intrinsic Pontine Glioma
2
Dendritic Cell Sarcoma, Interdigitating
2
Choroid Plexus Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
Sirolimus
3
Melphalan
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Automobiles
3
pembrolizumab
2
fludarabine
2
etoposide phosphate
2
Stem Cell Transplantation
2
Mesna
2
Immunotherapy
2
Gemcitabine
2
Etoposide
2
Carboplatin
2
Busulfan
2
vorasidenib
1
trametinib
1
tozuleristide
1
sonidegib
1
sodium thiosulfate
1
ripretinib
1
ribociclib
1
pegylated granulocyte colony-stimulating factor
1
lutetium Lu 177 dotatate
1
interferon gamma-1b
1
fludarabine phosphate
1
Watchful Waiting
1
Vorinostat
1
Ursodeoxycholic Acid
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Vorinostat
×
CNS
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled